These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34473289)

  • 41. Dehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells.
    Hsieh MJ; Lin CW; Chiou HL; Yang SF; Chen MK
    Oncotarget; 2015 Oct; 6(31):30831-49. PubMed ID: 26356821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.
    Robles AJ; Cai S; Cichewicz RH; Mooberry SL
    Breast Cancer Res Treat; 2016 Jun; 157(3):475-88. PubMed ID: 27255535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.
    Kutlehria S; Behl G; Patel K; Doddapaneni R; Vhora I; Chowdhury N; Bagde A; Singh M
    AAPS PharmSciTech; 2018 Feb; 19(2):792-802. PubMed ID: 29019073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
    Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
    Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
    Jabbarzadeh Kaboli P; Luo S; Chen Y; Jomhori M; Imani S; Xiang S; Wu Z; Li M; Shen J; Zhao Y; Wu X; Hin Cho C; Xiao Z
    Gene; 2022 Mar; 816():146171. PubMed ID: 35026293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.
    Singel SM; Cornelius C; Zaganjor E; Batten K; Sarode VR; Buckley DL; Peng Y; John GB; Li HC; Sadeghi N; Wright WE; Lum L; Corson TW; Shay JW
    Neoplasia; 2014 Mar; 16(3):247-56, 256.e2. PubMed ID: 24784001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.
    Massihnia D; Galvano A; Fanale D; Perez A; Castiglia M; Incorvaia L; Listì A; Rizzo S; Cicero G; Bazan V; Castorina S; Russo A
    Oncotarget; 2016 Sep; 7(37):60712-60722. PubMed ID: 27474173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
    Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
    PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway.
    Sharma P; Khan MA; Najmi AK; Chaturvedi S; Akhtar M
    Med Oncol; 2022 Oct; 39(12):248. PubMed ID: 36209343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moringa isothiocyanate complexed with α-cyclodextrin: a new perspective in neuroblastoma treatment.
    Giacoppo S; Iori R; Rollin P; Bramanti P; Mazzon E
    BMC Complement Altern Med; 2017 Jul; 17(1):362. PubMed ID: 28705212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of AKT signaling by supercritical CO2 extract of mango ginger (Curcuma amada Roxb.) in human glioblastoma cells.
    Ramachandran C; Portalatin G; Quirin KW; Escalon E; Khatib Z; Melnick SJ
    J Complement Integr Med; 2015 Dec; 12(4):307-15. PubMed ID: 26439597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy.
    Zhang S; Cui T; Duan Y; Zhang H; Wang B; Chen H; Ni J; Shen Y; Xiao-Ai Lv
    Clin Breast Cancer; 2022 Feb; 22(2):89-97. PubMed ID: 34535390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
    Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
    J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy.
    Ji S; Tang S; Li K; Li Z; Liang W; Qiao X; Wang Q; Yu S; Ye M
    Toxicol Appl Pharmacol; 2017 Jul; 326():25-33. PubMed ID: 28416456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer.
    Anestis A; Sarantis P; Theocharis S; Zoi I; Tryfonopoulos D; Korogiannos A; Koumarianou A; Xingi E; Thomaidou D; Kontos M; Papavassiliou AG; Karamouzis MV
    J Cancer Res Clin Oncol; 2019 May; 145(5):1221-1233. PubMed ID: 30805773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.
    Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J
    Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
    Zhang M; Kim HS; Jin T; Moon WK
    J Photochem Photobiol B; 2017 May; 170():58-64. PubMed ID: 28390259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.